GCTAX
Price
$58.68
Change
+$0.57 (+0.98%)
Updated
Sep 11 closing price
Net Assets
4.84B
VSTSX
Price
$360.74
Change
+$3.02 (+0.84%)
Updated
Sep 11 closing price
Net Assets
2.34T
Interact to see
Advertisement

GCTAX vs VSTSX

GCTAX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
GCTAX vs. VSTSX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCTAX is a Buy and VSTSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.34T vs. GCTAX (4.84B). VSTSX pays higher dividends than GCTAX: VSTSX (1.05) vs GCTAX (0.21). GCTAX was incepted earlier than VSTSX: GCTAX (26 years) vs VSTSX (10 years). GCTAX (1.05) is less costly to investors than VSTSX (0.01). GCTAX is a more actively managed with annual turnover of: 188.00 vs. VSTSX (3.00). GCTAX has a lower initial minimum investment than VSTSX: GCTAX (1000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 14.99 vs. GCTAX (13.35). GCTAX (63.54) and VSTSX (63.04) have equivalent 5 years return.
GCTAXVSTSXGCTAX / VSTSX
Total Expense Ratio1.010.0110,100%
Annual Report Gross Expense Ratio1.050.0110,500%
Fund Existence26 years10 years-
Gain YTD9.60011.35185%
Front Load6%N/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.84B2.34T0%
Annual Yield % from dividends0.211.0520%
Returns for 1 year13.3514.9989%
Returns for 3 years67.8268.8998%
Returns for 5 years63.5463.04101%
Returns for 10 years241.40245.0699%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVCT23.991.50
+6.67%
Nuvectis Pharma
ALZN1.720.02
+1.18%
Alzamend Neuro Inc.
SHIM3.44N/A
N/A
Shimmick Corp
AEE104.90-0.05
-0.05%
Ameren Corp
AVNT41.41-0.03
-0.08%
Avient Corp